1. Home
  2. Analysis
  3. Type-1-diabetes
  4. Glipizide

How effective is Glipizide for Type 1 Diabetes? (a real world drug study)

Summary:

Overall ratings: 3.3/5
Long term ratings: 3.3/5

This is a phase IV clinical study of how effective Glipizide (glipizide) is for Type 1 diabetes and for what kind of people. The study is created by eHealthMe from 15 Glipizide users and is updated continuously.

What is Glipizide?

Glipizide has active ingredients of glipizide. It is often used in diabetes. eHealthMe is studying from 64,852 Glipizide users. Check the latest studies of Glipizide.

What is Type 1 diabetes?

Type 1 diabetes is found to be associated with 668 drugs and 1,644 conditions by eHealthMe. Check the latest studies of Type 1 diabetes.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 17, 2026

15 people are studied for taking Glipizide in Type 1 diabetes

Overall effectiveness (number of people):

Does Glipizide work for your Type 1 diabetes (overall)?

Long term (1+ years) effectiveness (number of people):

Does Glipizide work for your Type 1 diabetes (long term)?

Glipizide effectiveness for Type 1 diabetes (number of people):

Overall:
  • not at all: 0
  • somewhat: 1
  • moderate: 9
  • high: 5
  • very high: 0
Long Term:
  • not at all: 0
  • somewhat: 1
  • moderate: 7
  • high: 5
  • very high: 0

Gender of people who take Glipizide for Type 1 diabetes *:

  • female: 46.67 %
  • male: 53.33 %

Age of people who take Glipizide for Type 1 diabetes *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 13.33 %
  • 40-49: 0.0 %
  • 50-59: 26.67 %
  • 60+: 60.0 %

Who find Glipizide more effective for Type 1 Diabetes?

Gender of people who take Glipizide for Type 1 diabetes *:

  • female: 60 %
  • male: 40 %

Age of people who take Glipizide for Type 1 diabetes *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 40 %
  • 60+: 60 %

* Approximation only. Some reports may have incomplete information.

Do you take Glipizide?

- You can start a phase IV clinical trial to monitor Glipizide safety and effectiveness.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Alternative drugs to, pros and cons of:

Treatments, associated drugs and conditions:

How the study uses the data?

The study is based on glipizide (the active ingredients of Glipizide) and Glipizide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.